Guidelines for liver transplantation in patients with HIV infection (2005)

HIV Medicine

Volumn 6, Issue SUPPL. 2, 2005, Pages 149-153

  O'Grady, J ^a   Taylor, C ^a   Brook, M Gary ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CALCINEURIN INHIBITOR; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

CHRONIC LIVER DISEASE; CLINICAL TRIAL; COUNSELING; DRUG POTENTIATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; META ANALYSIS; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

CHRONIC DISEASE; DATABASES, FACTUAL; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSION; LIVER DISEASES; LIVER TRANSPLANTATION; POSTOPERATIVE CARE;

EID: 22844450725     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2005.00303.x     Document Type: Review

References (32)

1. Yudkin JS, Beran D. Prognosis of diabetes in the developing world. Lancet 2003; 362: 1420.
2. Roper NA, Bilous RW, Kelly WF et al. Cause-specific mortality in a population with diabetes. South Tees Diabetes Mortality Study. Diabetes Care 2002; 25: 43-48.
3. Mocroft A, Brettle R, Kirk O et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS 2002; 16: 1663-1671.
4. Thio CL, Seaberg EC, Skolasky R et al. Liver disease mortality in HIV-HBV co-infected persons. Ninth Conference on Retroviruses and Opportunistic Infections, Seattle, 2002 [Abstract 656].
5. Benhamou Y, Bochet M, Di Martino V et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus co-infected patients. The Multivirc Group. Hepatol 1999; 30: 1054-1058.
6. Soto B, Sanchez-Quijano A, Rodrigo L et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26: 1-5.
7. Rockstroh J, Konopnicki D, Soriano V et al. Hepatitis B and Hepatitis C in the EuroSIDA cohort: prevalence and effect on mortality, AIDS progression and response to HAART. 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, 2004 [Abstract 799].
8. Beck EJ, Mandalia S, Leonard K et al. Case-control study of sexually transmitted diseases as cofactors for HIV-1 transmission. Int J STD AIDS 1996; 7: 34-38.
9. Rudge CJ, Fuggle SV, Burbidge KM. Geographic disparities in access to organ transplantation in the United Kingdom. Transplantation 2003; 76: 1395-1398.
10. Devlin J, O-Grady J. Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology. Gut 1999; 45 (Suppl. 6): VI1-VI22.
11. Neuberger J, James O. Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage. Lancet 1999; 354: 1636-1639.
12. Soriano V, Miró JM, García SJ et al. Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations. J Viral Hepat 2004; 11: 2-17.
13. Ragni W, Belle SH, Im-Kyung AH et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 2003; 188: 1412-1420.
14. Fung J, Eghtesad B, Patel TK et al. Liver transplantation in patients with HIV infection. Liver Transpl 2004; 10 (Suppl. 2): S39-S53.
15. Norris S, Taylor C, Muiesan P et al. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl 2004; 10: 1271-1278.
16. Neff G, Bonham A, Tzakis AG et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 2003; 9: 239-247.
17. Roland ME, Stock PG. Review of solid-organ transplantation in HIV-infected patients. Transplantation 2003; 75: 425-429.
18. Adam R, McMaster PO, -Grady JG et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 2003; 9: 1231-1243.
19. Neuberger J. Hope or efficacy in donor liver allocation? Transplantation 2001; 72: 1173-1176.
20. Everhart JE, Lombardero M, Detre KM et al. Increased waiting time for liver transplantation results in higher mortality. Transplantation 1997; 64: 1300-1306.
21. Ravaioli M, Ercolani G, Cescon M et al. Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. Liver Transpl 2004; 10: 1195-1202.
22. Fernández JA, Robles R, Marin C et al. Can we expand the indications for liver transplantation among hepatocellular carcinoma patients with increased tumor size? Transplant Proc 2003; 35: 1818-1820.
23. Mela M, Mancuso A, Burroughs AK. Hepatocellular carcinoma: indications for liver transplantation. Aliment Pharmacol Ther 2003; 17 (Suppl. 2): 130-137.
24. Yao FY, Ferrell L, Bass NM et al. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002; 8: 765-774.
25. Fisher RA, Maluf D, Cotterell AH et al. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Clin Transplant 2004; 18: 502-512.
26. Wong LL, Tanaka K, Lau L et al. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers. Clin Transplant 2004; 18: 227-234.
27. Takamori R, Wong LL, Dang C et al. Needle-tract implantation from hepatocellular cancer: is needle biopsy of the liver always necessary? Liver Transpl 2000; 6: 67-72.
28. Caturelli E, Ghittoni G, Roselli P et al. Fine needle biopsy of focal liver lesions: the hepatologist's point of view. Liver Transpl 2004; 10 (Suppl. 1): S26-S29.
29. Jain AKB, Venkataramanan R, Shapiro R et al. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl 2002; 8: 841-845.
30. Casanovas TT. Impact of cyclosporine on the development of immunosuppressive therapy in liver transplantation. Transplant Proc 2004; 36 (2 Suppl.): 291S-294S.
31. Bravata DM, Olkin I, Barnato AE et al. Health-related quality of life after liver transplantation: a meta-analysis. Liver Transpl Surg 1999; 5: 318-331.
32. Blanch J, Sureda B, Flavia M et al. Psychosocial adjustment to orthotopic liver transplantation in 266 recipients. Liver Transpl 2004; 10: 228-234.